Josh Levitsky
Overview
Explore the profile of Josh Levitsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
2510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Stark H, Ho Q, Cross A, Alessandrini A, Bertaina A, Brennan D, et al.
Transplantation
. 2025 Jan;
PMID: 39800883
No abstract available.
3.
Madill-Thomsen K, Gauthier P, Abouljoud M, Bhati C, Bruno D, Ciszek M, et al.
Transplantation
. 2025 Jan;
PMID: 39780312
Background: Initial analysis of liver transplant biopsies in the INTERLIVER study (ClinicalTrials.gov; unique identifier NCT03193151) using rejection-associated transcripts failed to find an antibody-mediated rejection state (ie, rich in natural killer...
4.
Cravedi P, Maggiore U, Molinari P, Levitsky J, Zorn E
Transplantation
. 2025 Jan;
109(3):411-417.
PMID: 39748180
Chronic rejection is arguably the main obstacle to long-term graft survival. Yet, clinical trials focusing on this condition are disappointingly scarce. Significant advances in treating chronic rejection cannot happen if...
5.
St Hillien S, Robinson J, Ouyang T, Patidar K, Belcher J, Cullaro G, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39675402
Background & Aims: Chronic kidney disease (CKD) frequency is increasing in patients with cirrhosis and these individuals often experience acute kidney injury (AKI). Direct comparisons of outcomes between AKI-only versus...
6.
Angelico R, Levitsky J
Am J Transplant
. 2024 Dec;
25(3):461-462.
PMID: 39638045
No abstract available.
7.
Tanimine N, Markmann J, Wood-Trageser M, Demetris A, Mason K, Silva J, et al.
Am J Transplant
. 2024 Nov;
PMID: 39505152
Immunosuppression can be withdrawn from selected liver transplant recipients, although robust clinical predictors of tolerance remain elusive. The Immune Tolerance Network ITN056ST study (OPTIMAL; NCT02533180) assessed clinical outcomes and mechanistic...
8.
Goerlich N, Kim-Schulze S, Kotanko P, Grobe N, Wang X, Samans B, et al.
Front Transplant
. 2024 Oct;
3:1480383.
PMID: 39440014
Kidney injury is a significant complication in end-stage liver disease (ESLD), leading to increased morbidity and mortality. While liver transplant alone (LTA) can promote kidney recovery (KR), non-recovery associates with...
9.
Saravanan N, Demetris A, Fiel M, Harrington C, Khurram N, Schiano T, et al.
Am J Transplant
. 2024 Oct;
25(2):259-268.
PMID: 39393458
The distinction between autoimmune and alloimmune reactions in liver transplant recipients can be challenging. Plasma cell-rich rejection (PCRR), previously known as de novo autoimmune hepatitis or plasma cell hepatitis, is...
10.
Cama-Olivares A, Ouyang T, Takeuchi T, St Hillien S, Robinson J, Chung R, et al.
Kidney360
. 2024 Sep;
6(2):247-256.
PMID: 39348201
No abstract available.